Bloomberg Talks

Cristiano Amon, CEO of Qualcomm and a leader in tech innovations, dives into the challenges faced in the smartphone market. He emphasizes Qualcomm's strategic pivot toward diversification, spotlighting growth in IoT and automotive sectors. Amon discusses the company’s ambitious goals for non-handset revenue by 2029 and highlights advancements in AI and computing. With Qualcomm's focus on digital cockpits and smart glasses, Amon showcases how innovation drives new opportunities despite industry competition.

Dylan Field, the CEO of Figma, a pioneering collaborative design software company, shares insights into their recent IPO at a whopping $20 billion valuation. He emphasizes the transformative power of design in tech and how it is now a competitive edge. Field dives into Figma's innovative use of generative AI to enhance the design process and discusses their commitment to long-term growth over immediate profits. He also hints at future mergers and acquisitions, underscoring the importance of cultural alignment in expanding Figma's capabilities.

Vlad Tenev, CEO of Robinhood Markets, dives into his company's impressive second-quarter earnings, which exceeded analysts' expectations, and its rising valuation now surpassing Intel. He shares exciting plans for Robinhood's global expansion, aiming to transform it into a financial super app that goes beyond just retail customers. Tenev also highlights the shift in market dynamics, with retail investors gaining influence, plus how AI will enhance business efficiency. This insightful discussion sheds light on Robinhood’s innovative growth strategies.

Dan Ives discusses soaring earnings for Microsoft and Meta, thanks to AI innovations fueling their growth. He delves into the competitive landscape, highlighting Microsoft's dominance in AI and cloud services. Concerns over Apple's market position amid these transformations also emerge. With the rise of AI, there's a compelling forecast for market cap increases for tech giants like Microsoft and NVIDIA.

Airbus is grappling with significant supply chain challenges, especially regarding engine deliveries that are delaying aircraft production. Despite these hurdles, the company finds itself with strong demand and a robust backlog of orders. The discussion dives into the strategies for increasing A320 production amidst these setbacks. Additionally, the potential impact of a US-EU trade agreement on Airbus's operations is explored, highlighting both the challenges and opportunities on the horizon.

Jim Farley, CEO of Ford Motor Co., explores the challenges posed by tariffs, revealing their expected impact on profits during the year. He discusses Ford's strong second-quarter earnings, beating estimates despite pressures. Farley elaborates on the company's focus on expanding its electric vehicle offerings and the strategic shift towards affordability in the EV market. He also shares insights on ongoing discussions aimed at improving conditions for U.S. auto manufacturing as Ford navigates the complexities of the current economic landscape.

Teva Pharmaceutical's recent financial results reveal a mixed performance amid strategic shifts. CEO Richard Francis discusses the potential effects of new U.S.-EU tariffs on drug pricing and how they complicate the industry landscape. The conversation also touches on the need for clearer governmental guidance. Innovations in biopharma come to light, particularly regarding pricing strategies and potential divestitures. Lastly, the role of artificial intelligence in improving operational efficiencies takes center stage.

Sergio Ermotti discusses UBS's impressive $2.4 billion net income, surpassing expectations, and emphasizes the bank's strength in global diversification. He tackles Switzerland's upcoming bank capital rules and insists that shrinking is not an option. The conversation also delves into the complexities of trade negotiations, potential tariffs, and their inflationary impacts. Ermotti highlights concerns from clients regarding trade uncertainties and the critical need for stable agreements to restore market confidence.

Democratic Senator Elizabeth Warren from Massachusetts, known for her advocacy on economic policy, joins hosts Joe Mathieu and Kailey Leinz. She discusses the Federal Reserve's crucial role in lowering interest rates to alleviate financial strain on families. Warren highlights the urgent US housing crisis, advocating for bipartisan efforts to boost housing supply amid rising prices. The conversation also touches on the significant distractions in Congress, particularly the implications of the Epstein case, urging lawmakers to focus on pressing issues like housing.

Pascal Soriot, CEO of AstraZeneca and former Genentech CEO, shares insights into the pharmaceutical giant's future. He discusses plans to potentially sell medicines directly to U.S. patients, emphasizing AstraZeneca’s goal of self-sufficiency in the U.S. market soon. Soriot delves into how U.S. policies and a $50 billion commitment are reshaping domestic manufacturing. He also highlights China’s evolution in drug innovation and the need for U.S. firms to adapt to stay competitive while ensuring breakthroughs in therapies for obesity and cancer.